1346451-86-2

Upstream product

• 41979-39-9 4-piperidone hydrochloride 
• 352-11-4 1-chloromethyl-4-fluorobenzene 
• 134348-51-9 1-(4-Fluorobenzyl)-4-piperidone 
• 13466-41-6 2-hydroksy-4-methyl-pyridine 
• 1346452-04-7 N-(4-fluorobenzyl)-1-oxa-6-azaspiro[2,5]-octane 
• 793-19-1 bis(2-methoxycarbonylethyl)benzylamine 
• 100-46-9 benzylamine 
• 19867-34-6 N-benzyl-1-oxa-6-azaspiro[2,5]-octane 
• 3612-20-2 1-phenylmethyl-4-piperidone 

Relevant academic research and scientific papers

1-[(4-HYDROXYPRIDIN-4-YL) METHYL]PYRIDINE-2(1H)-ONE DERIVATIVES, PREPARATION METHODS AND USES THEREOF

Provided are N-[(4-hydroxypiperidin-4-yl)methyl]pyridin-2(1H)-one derivatives represented by formula I, stereoisomers, pharmaceutically acceptable salts or solvates thereof

1-[(4-hydroxypiperidin-4-yl)methyl]pyridin-2(1H)-one derivatives, preparation methods and uses thereof

Provided are N-[(4-hydroxypiperidin-4-yl)methyl]pyridin-2(1H)-one derivatives represented by formula I, stereoisomers, pharmaceutically acceptable salts or solvates thereof. The above compounds have the dual activities of 5-hydroxytryptamine 1A receptor ligand and selective serotonin reuptake inhibitor. The preparation methods of the above compounds, the uses of these compounds for the prevention or treatment of nervous system diseases related to 5-hydroxytryptamine system dysfunction and the pharmaceutical compositions containing these compounds are also provided.